Effect of tapentadol extended release on productivity: Results from an analysis combining evidence from multiple sources

Clinical Journal of Pain

Volumn 28, Issue 1, 2012, Pages 8-13

  Cepeda, M Soledad ^a   Sutton, Alex ^b   Weinstein, Rachel ^a   Kim, Myoung ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Comparative effectiveness research; Constipation; Multiparameter evidence synthesis; Opioid; Productivity; Tapentadol

Indexed keywords

OXYCODONE; TAPENTADOL;

ANALGESIA; ARTICLE; CHRONIC PAIN; CONSTIPATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HUMAN; PRIORITY JOURNAL; PRODUCTIVITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); WORK DISABILITY; WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT QUESTIONNAIRE; WORKING TIME;

EID: 84856273633     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3182201983     Document Type: Article

References (24)

1. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med. 2009;151:W65-W94.
2. Sutton A, Ades AE, Cooper N, et al. Use of indirect and mixed treatment comparisons for technology assessment. Pharmacoeconomics. 2008;26:753-767.
3. Cooper NJ, Sutton AJ, Lu G, et al. Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. Arch Intern Med. 2006;166:1269-1275. (Pubitemid 43967578)
4. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105-3124. (Pubitemid 39334902)
5. Cooper NJ, Sutton AJ, Morris D, et al. Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med. 2009;28:1861-1881.
6. Ades AE. A chain of evidence with mixed comparisons: Models for multi-parameter synthesis and consistency of evidence. Stat Med. 2003;22:2995-3016. (Pubitemid 37160601)
7. Ades AE, Sutton AJ. Multiparameter evidence synthesis in epidemiology and medical decision-making: Current approaches. J R Stat Soc Ser A Stat Soc. 2006;169:5-35. (Pubitemid 43423877)
8. Kress HG. Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally-acting analgesics on the horizon? Eur J Pain. 2010;14:781-783.
9. Afilalo M, Etropolski MS, Kuperwasser B, et al. Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: A randomized, double-blind, placebo- and active-controlled phase III study. Clin Drug Investig. 2010;30:489-505.
10. Buynak R, Shapiro DY, Okamoto A, et al. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: Results of a prospective, randomized, doubleblind, placebo- and active-controlled Phase III study. Expert Opin Pharmacother. 2010;11:1787-1804.
11. Lange B, Kuperwasser B, Okamoto A, et al. Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain. Adv Ther. 2010;27:381-399.
12. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg. 2001;182:S11-S18.
13. Ahmedzai SH, Boland J. Constipation in people prescribed opioids. Clin Evid (Online). 2007;pii:2407.
14. Johanson JF, Kralstein J. Chronic constipation: A survey of the patient perspective. Aliment Pharmacol Ther. 2007;25:599-608.
15. Wald A, Scarpignato C, Kamm MA, et al. The burden of constipation on quality of life: Results of a multinational survey. Aliment Pharmacol Ther. 2007;26:227-236. (Pubitemid 46985504)
16. Dennison C, Prasad M, Lloyd A et al. The health-related quality of life and economic burden of constipation. Pharmacoeconomics. 2005;23:461-476. (Pubitemid 40994135)
17. Frampton JE. Tapentadol immediate release: A review of its use in the treatment of moderate to severe acute pain. Drugs. 2010;70:1719-1743.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558. (Pubitemid 34746062)
19. Lambert PC, Sutton AJ, Burton PR et al. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med. 2005;24: 2401-2428. (Pubitemid 41093922)
20. Bell T, Annunziata K, Leslie JB. Opioid-induced constipation negatively impacts pain management, productivity, and healthrelated quality of life: Findings from the National Health and Wellness Survey. J Opioid Manag. 2009;5:137-144.
21. MRC Biostatistics Unit CU. The BUGS project: WinBUGS. Available at: Http://www.mrc-bsu.cam.ac.uk/bugs/winbugs/ contents.shtml. Accessed September 27, 2010.
22. Cepeda MS, Etropolski M, Weinstein R, et al. Dose patterns in commercially insured subjects chronically exposed to opioids: A large cohort study in the United States. BMC Palliative Care. 2010;9:14.
23. Noble M, Tregear SJ, Treadwell JR, et al. Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage. 2008;35:214-228.
24. Allegretto SA. U.S. workers enjoy far fewer vacation days than Europeans 2005. Available at: Http://www.epi.org/ economic-snapshots/entry/webfeatures- snapshots-20050824/ (Accessed December 10, 2010).